October 13, 2026 |
On October 6, 2026, ArriVent BioPharma, Inc. announced that its global Phase 3 FURVENT trial evaluating firmonertinib in previously untreated patients with EGFR exon 20 insertion-mutated non-small-cell lung cancer failed to meet its primary endpoint of progression-free survival. Previously, the Company had stated in a… read more
October 12, 2026 |
On October 1, 2026, Foghorn Therapeutics Inc. announced that, following a review of clinical data from the Phase 1 dose-escalation trial of FHD-909 (LY4050784), the Company and its collaboration partner, Eli Lilly, decided not to advance the program into the clinical development expansion phase. The… read more
October 12, 2026 |
On August 18, 2026, La-Z-Boy Incorporated reported disappointing first-quarter fiscal 2027 financial results, missing analysts’ expectations for both revenue and earnings. The Company reported revenue of approximately $476 million and adjusted earnings of $0.43 per share, compared to analysts’ expectations of approximately $501 million and… read more
October 12, 2026 |
On October 2, 2026, Evolus, Inc. revealed that it had received a warning letter from the U.S. Food and Drug Administration (FDA) concerning allegedly false or misleading Instagram promotions of its wrinkle treatment, Jeuveau. According to the FDA, the Company’s promotional materials minimized important safety… read more
October 12, 2026 |
On September 28, 2026, Pasqal Holding SA announced that it was terminating its participation in France’s LSQUARE/PROQCIMA defense program following completion of the program’s first phase. The Company stated that it would instead focus its collaboration with French public authorities on commercial applications. Following this… read more
October 12, 2026 |
October 8, 2026 |
By Nathan Miller Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Fervo Energy Company (“Fervo” or “the Company”) (NASDAQ: FRVO). Investors who purchased Fervo securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether… read more
October 7, 2026 |
By Nathan Miller Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Lennar Corporation (“Lennar” or “the Company”) (NYSE: LEN). Investors who purchased Lennar securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Lennar… read more
October 6, 2026 |
By Nathan Miller Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of TruGolf Holdings, Inc. (“TruGolf” or “the Company”) (NASDAQ: TRUG). Investors who purchased TruGolf securities prior to September 10, 2025, and continue to hold to the present, are encouraged… read more
October 6, 2026 |
By Nathan Miller Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Rackspace Technology, Inc. (“Rackspace” or “the Company”) (NASDAQ: RXT). Investors who purchased Rackspace securities prior to May 7, 2026, and continue to hold to the present, are encouraged… read more
October 6, 2026 |
By Nathan Miller Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of TruGolf Holdings, Inc. (“TruGolf” or “the Company”) (NASDAQ: TRG). Investors who purchased TruGolf securities prior to September 10, 2025, and continue to hold to the present, are encouraged… read more
October 6, 2026 |
By Nathan Miller Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Bloom Energy Corporation (“Bloom Energy” or “the Company”) (NYSE: BE). Investors who purchased Bloom Energy securities prior to February 27, 2026, and continue to hold to the present,… read more
October 5, 2026 |
By Nathan Miller Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ClearPoint Neuro, Inc. (“ClearPoint” or “the Company”) (NASDAQ: CLPT). Investors who purchased ClearPoint securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether… read more
October 5, 2026 |
By Nathan Miller Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Neogen Corporation (“Neogen” or “the Company”) (NASDAQ: NEOG). Investors who purchased Neogen securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Neogen… read more
October 5, 2026 |
By Nathan Miller Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Liquidia Corporation (“Liquidia” or “the Company”) (NASDAQ: LQDA). Investors who purchased Liquidia securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Liquidia… read more
October 5, 2026 |
By Nathan Miller Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Fair Isaac Corporation (“Fair Isaac” or “the Company”) (NYSE: FICO). Investors who purchased Fair Isaac securities are encouraged to obtain additional information and assist the investigation. The investigation… read more
October 5, 2026 |
By Nathan Miller Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of uniQure N.V. (“uniQure” or “the Company”) (NASDAQ: QURE). Investors who purchased uniQure securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether uniQure… read more
October 5, 2026 |
By Nathan Miller Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Alignment Healthcare, Inc. (“Alignment Healthcare” or “the Company”) (NASDAQ: ALHC). Investors who purchased Alignment Healthcare securities are encouraged to obtain additional information and assist the investigation. The investigation… read more
October 5, 2026 |
By Nathan Miller Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Nidec Corporation (“Nidec” or “the Company”) (OTCMKTS: NJDCY). Investors who purchased Nidec securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Nidec… read more
October 5, 2026 |
By Nathan Miller Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Azenta, Inc. (“Azenta” or “the Company”) (NASDAQ: AZTA). Investors who purchased Azenta securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Azenta… read more
October 5, 2026 |
By Nathan Miller Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Integra LifeSciences Holdings Corporation (“Integra LifeSciences” or “the Company”) (NASDAQ: IART). Investors who purchased Integra LifeSciences securities are encouraged to obtain additional information and assist the investigation. The… read more
October 5, 2026 |
By Nathan Miller Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of DoorDash, Inc. (“DoorDash” or “the Company”) (NASDAQ: DASH). Investors who purchased DoorDash securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether DoorDash… read more
September 30, 2026 |
By Nathan Miller Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Zscaler, Inc. (“Zscaler” or “the Company”) (NASDAQ: ZS). Investors who purchased Zscaler securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Zscaler… read more
September 29, 2026 |
By Nathan Miller Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Deep Fission, Inc. (“Deep Fission” or “the Company”) (NYSE: FISN). Investors who purchased Deep Fission securities are encouraged to obtain additional information and assist the investigation. The investigation… read more
September 29, 2026 |
By Nathan Miller Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Flutter Entertainment plc (“Flutter” or “the Company”) (NYSE: FLUT). Investors who purchased Flutter securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether… read more
September 29, 2026 |
By Nathan Miller Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Medline Inc. (“Medline Inc.” or “the Company”) (NASDAQ: MDLN). Investors who purchased Medline Inc. securities are encouraged to obtain additional information and assist the investigation. The investigation concerns… read more
September 29, 2026 |
By Nathan Miller Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Kinross Gold Corporation (“Kinross” or “the Company”) (NYSE: KGC). Investors who purchased Kinross securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether… read more
September 29, 2026 |
By Nathan Miller Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of The Boeing Company (“Boeing” or “the Company”) (NYSE: BA). Investors who purchased Boeing securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether… read more
September 29, 2026 |
By Nathan Miller Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ACADIA Pharmaceuticals Inc. (“Acadia” or “the Company”) (NASDAQ: ACAD). Investors who purchased Acadia securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether… read more
September 28, 2026 |
By Nathan Miller Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of EquipmentShare.com Inc. (“EquipmentShare.com” or “the Company”) (NASDAQ: EQPT). Investors who purchased EquipmentShare.com securities prior to January 23, 2026, and continue to hold to the present, are encouraged to… read more